Biological

Anti-CEA CAR T Cells clinical trials

studies test it: 11
open now: 2
in phase 3: 1
first study started: 2008

Keep track of what changes. Save the Anti-CEA CAR T Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

anti-CEA CAR-T cells: 5
Designer T cells: 5
CEA CAR-T cells: 4

Studies by the year they started

11 studies that test it; most in 2021 (2)

Studies that test Anti-CEA CAR T Cells, by start year
Year	Studies
2008	1
2011	1
2015	1
2017	1
2018	1
2020	1
2021	2
2022	2
2023	1

By phase

A phase 1/2 study counts in both.

Phase 1: 10
Phase 2: 2
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Colorectal Neoplasms: 4
Neoplasm Metastasis: 3
Cholangiocarcinoma: 1
Lung Neoplasms: 1
Adenocarcinoma: 1
Pancreatic Neoplasms: 1

Who runs them

Industry 5 · Other 6

Roger Williams Medical Center (4) · Chongqing Precision Biotech Co., Ltd (3) · Sorrento Therapeutics, Inc. (2) · Weijia Fang, MD (1) · Changhai Hospital (1)

Often tested with

Tested in the same studies.

GNP Regimen (1) · Irinotecan (1) · Irinotecan sucrosofate (1) · Capecitabine (1)

Studies

Open first, then newest update. How each study uses Anti-CEA CAR T Cells is read from its arms, and is right about nine times in ten.